Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANARY: CDT vs Anticoagulation in Acute PE
NCT05172115Phase 3Terminated
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Dec 2018
- Primary completion
- Feb 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in pulmonary embolism (PE), sponsored by Rajaie Cardiovascular Medical and Research Center. Started Dec 2018; status: terminated.
02
Drugs
tissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT05172115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05172115.